STAAR Surgical Company (STAA) |
| 24.43 -2.41 (-8.98%) 04-14 16:00 |
| Open: | 26.61 |
| High: | 26.625 |
| Low: | 24.43 |
| Volume: | 2,039,032 |
| Market Cap: | 1,210(M) |
| PE Ratio: | -15.08 |
| Exchange: | NASDAQ Global Market |
| Industry: | Medical - Instruments & Supplies |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 31.42 |
| Resistance 1: | 26.90 |
| Pivot price: | 21.14 |
| Support 1: | 20.68 |
| Support 2: | 16.83 |
| 52w High: | 30.81 |
| 52w Low: | 15.59 |
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone cataract intraocular lenses and injector systems for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
| EPS | -1.620 |
| Book Value | 6.970 |
| PEG Ratio | 0.00 |
| Gross Profit | 3.685 |
| Profit Margin (%) | -33.60 |
| Operating Margin (%) | -18.87 |
| Return on Assets (ttm) | -5.9 |
| Return on Equity (ttm) | -21.7 |
Tue, 14 Apr 2026
Staar Surgical Co (STAA) Shares Fall 9.1% -- What GF Score of 78 Tells Investors - GuruFocus
Tue, 14 Apr 2026
STAAR Surgical Company (NASDAQ:STAA) Q4 2025 earnings call transcript - MSN
Fri, 10 Apr 2026
Is It Time To Reassess STAAR Surgical (STAA) After The Alcon Agreement Update - simplywall.st
Thu, 09 Apr 2026
STAAR Surgical: Q1 Preliminary Revenues Justify Decision To Reject Alcon Bid (NASDAQ:STAA) - Seeking Alpha
Thu, 09 Apr 2026
Why Did STAAR Surgical (STAA) Stock Jump 20% After Hours? - Benzinga
Wed, 08 Apr 2026
STAAR Surgical stock surges 18% on strong Q1 sales beat - Investing.com
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |